7 studies found for:    Gilead | Nafld
Show Display Options
Rank Status Study
1 Recruiting Safety, Tolerability, and Efficacy of GS-4997 in Adults With Hepatic Steatosis and Elevated Liver Stiffness
Condition: Non-alcoholic Fatty Liver Disease (NAFLD)
Intervention: Drug: GS-4997
2 Active, not recruiting Simtuzumab (GS-6624) in the Treatment of Cirrhosis Due to NASH
Condition: Non-Alcoholic Steatohepatitis (NASH)
Interventions: Biological: Simtuzumab;   Biological: Placebo
3 Active, not recruiting Safety and Efficacy of Simtuzumab (GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Condition: Non-Alcoholic Steatohepatitis (NASH)
Interventions: Biological: Simtuzumab;   Biological: Placebo
4 Active, not recruiting Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3
Condition: Non-Alcoholic Steatohepatitis (NASH)
Interventions: Drug: GS-4997;   Biological: SIM
5 Not yet recruiting Pharmacokinetics and Pharmacodynamics of GS-9674 in Adults With Normal and Impaired Hepatic Function
Condition: Nonalcoholic Steatohepatitis (NASH)
Intervention: Drug: GS-9674
6 Active, not recruiting Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-9674, and the Effect of Food on GS-9674 Pharmacokinetics and Pharmacodynamics
Condition: Nonalcoholic Steatohepatitis (NASH)
Interventions: Drug: GS-9674;   Drug: Placebo
7 Completed Safety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults With Non-Alcoholic Steatohepatitis (NASH)
Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: GS-9450;   Drug: GS-9450 Placebo

Indicates status has not been verified in more than two years